Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Divests German BioReliance Manufacturing Unit to Investor Group; Business Not Aligned With Invitrogen s Goals

This update serves to clarify that Invitrogen has divested the Heidelberg, Germany-based unit of its BioReliance business. The BioReliance business itself, which Invitrogen will retain, is based in Rockville, Md. The original story was based on a press release that did not describe the relationship between the Heidelberg and Rockville businesses.

NEW YORK, April 27 (GenomeWeb News) - Invitrogen has sold its BioReliance Manufacturing business to a consortium of investors led by BioReliance's managing director, the company said today.

 

After the management buy-out, which was led by Thomas Pultar, the company will be called BIOMEVA.

 

BioReliance Manufacturing is based in Heidelberg, Germany. It is a "small part" of the overall BioReliance business, based in Rockville, Md., which Invitrogen will retain, according to a company spokesperson.

 

Terms of the divestiture were not disclosed. Invitrogen acquired Rockville-based BioReliance in December 2003 for $500 million.

 

"Bacterial contract manufacturing was not aligned with our strategic direction," Bernd Brust, vice president and general manager for Invitrogen Europe, said in a statement.

 

BioReliance Manufacturing offers fermentation and purification services using recombinant and natural microorganisms. The new company will continue this model, it said.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.